Full Text:   <2198>

CLC number: R587

On-line Access: 

Received: 2007-04-03

Revision Accepted: 2007-09-19

Crosschecked: 0000-00-00

Cited: 9

Clicked: 4937

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2007 Vol.8 No.12 P.875~880

http://doi.org/10.1631/jzus.2007.B0875


Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris


Author(s):  Qiao Xiao-zhi, Yang Yun-mei, Xu Zhe-rong, Yang Li-ai

Affiliation(s):  Department of Very Important Person, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China

Corresponding email(s):   qxz1971@hzcnc.com, gbbf2000@sina.com

Key Words:  Resistin, Acute coronary syndrome (ACS), Stable angina pectoris (SAP)


Qiao Xiao-zhi, Yang Yun-mei, Xu Zhe-rong, Yang Li-ai. Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris[J]. Journal of Zhejiang University Science B, 2007, 8(12): 875~880.

@article{title="Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris",
author="Qiao Xiao-zhi, Yang Yun-mei, Xu Zhe-rong, Yang Li-ai",
journal="Journal of Zhejiang University Science B",
volume="8",
number="12",
pages="875~880",
year="2007",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2007.B0875"
}

%0 Journal Article
%T Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris
%A Qiao Xiao-zhi
%A Yang Yun-mei
%A Xu Zhe-rong
%A Yang Li-ai
%J Journal of Zhejiang University SCIENCE B
%V 8
%N 12
%P 875~880
%@ 1673-1581
%D 2007
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2007.B0875

TY - JOUR
T1 - Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris
A1 - Qiao Xiao-zhi
A1 - Yang Yun-mei
A1 - Xu Zhe-rong
A1 - Yang Li-ai
J0 - Journal of Zhejiang University Science B
VL - 8
IS - 12
SP - 875
EP - 880
%@ 1673-1581
Y1 - 2007
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2007.B0875


Abstract: 
Objective: To investigate the relationship between serum resistin level and acute coronary syndrome (ACS) or stable angina pectoris (SAP). Methods: Sixty-five patients, with coronary artery disease, were enrolled and divided into three subgroups: acute myocardial infarction (AMI), unstable angina pectoris (UAP) and SAP, and 26 healthy people were recruited as controls in the cross-sectional study. Serum resistin levels were determined by ELISA (enzyme-linked immunosorbent assay), and WBC (white blood cell count), hsCRP (high sensitive C-reaction protein), CKmax (maximum of creatinkinase), CK-MBmax (maximum of isozyme of creatinkinase) and cTnImax (maximum of troponin) were measured by standard laboratory methods. Results: The serum resistin levels were 4 folds higher in AMI patients, 2.43 folds in UAP patients and 1.12 folds in SAP patients than in the healthy controls (P<0.05). The resistin levels were also significantly different between AMI [(8.16±0.79) ng/ml], UAP [(5.59±0.75) ng/ml] and SAP [(3.45±0.56) ng/ml] groups (P<0.01); WBC, hsCRP, CKmax, CK-MBmax and cTnImax were significantly increased in AMI patients over UAP and SAP patients. Spearman analysis showed that serum resistin levels were positively correlated with WBC (r=0.412, P=0.046), hsCRP (r=0.427, P=0.037), CKmax, CK-MBmax and cTnImax (r=0.731, 0.678, 0.656; P<0.01). Conclusion: Serum resistin levels increased with inflammatory factors and myocardial impairment. The results suggest that human resistin might play an important role in the pathogenesis of atherosclerosis and AMI as an inflammatory factor.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1] Agwunobi, A., Reid, C., Maycock, P., Little, R.A., Carlson, G.L., 2000. Insulin resistance and substrate utilization in human endotoxemia. J. Clin. Endocrinol. Metab., 85(10):3770-3778.

[2] Burnett, M.S., Lee, C.W., Kinnaird, T.D., Stabile, E., Durrani, S., Dullum, M.K., Devaney, J.M., Fishman, C., Stamou, S., Canos, D., et al., 2005. The potential role of resistin in atherogenesis. Atherosclerosis, 182(2):241-248.

[3] Calabro, P., Samudio, I., Willerson, J.T., 2004. Resistin promotes smooth muscle cell proliferation through activation of extra cellular signal regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation, 110(21):3335-3340.

[4] Fan, H.Q., Gu, N., Liu, F., Pan, X.Q., Guo, M., Chen, R.H., Guo, X.R., 2007. Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles. Acta Pharmacol. Sin., 28(3):410-416.

[5] Hotamisligil, G.S., Spiegelman, B.M., 1994. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes, 43(11):1271-1278.

[6] Kaser, S., Kaser, A., Sandhofer, A., 2003. Resistin messenger-RNA expression is increased by proinflammatory cytcokines in vitro. Biochem. Biophys. Res. Commun., 309(2):286-290.

[7] Kawanami, D., Maemura, K., Takeda, N., Harada, T., Nojiri, T., Imai, Y., Manabe, I., Utsunomiya, K., Nagai, R., 2004. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun., 314(2):415-419.

[8] Kunnari, A., Ukkola, O., Paivansalo, M., Kesaniemi, Y.A., 2006. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J. Clin. Endocrinal. Metab., 91(7):2755-2760.

[9] Lehrke, M., Reilly, M.P., Millington, S.C., Iqbal, N., Rader, D.J., Lazar, M.A., 2004. An inflammatory cascade leading to hyperresistinemia in humans. Plos. Med., 1(2):e45.

[10] Lubos, E., Messow, C., Schnabel, R., Rupprecht, H., Espinola-Klein, C., Bickel, C., Peetz, D., Post, F., Lackner, K., Tiret, L., 2007. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Athero-sclerosis, 193(1):121-128.

[11] Lyon, C.J., Law, R.E., Hsueh, W.A., 2003. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology, 144(6):2195-2200.

[12] Mather, K.J., Verma, S., Anderson, T.J., 2001. Improved endothelial function with metformin in type 2 diabetes mellitus. J. Am. Coll. Cardiol., 37(5):1344-1350.

[13] Matsuzawa, Y., Funahashi, T., Nakamura, T., 1999. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocytederived bioactive substances. Ann. N. Y. Acad. Sci., 892:146-154.

[14] Ohmori, R., Momiyama, Y., Kato, R., Taniguchi, H., Ogura, M., Ayaori, M., Nakamura, H., Ohsuzu, F., 2005. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J. Am. Coll. Cardiol., 46(2):379-380.

[15] Patel, L., Buckels, A.C., Kinghorn, I.J., Murdock, P.R., Holbrook, J.D., Plumpton, C., Macphee, C.H., Smith, S.A., 2003. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun., 300(2):472-476.

[16] Pischon, T., Bamberger, C.M., Kratzsch, J., Zyriax, B.C., Algenstaedt, P., Boeing, H., Windler, E., 2005. Association of plasma resistin levels with coronary heart disease in women. Obes. Res., 13(10):1764-1771.

[17] Rajala, M.W., Obici, S., Scherer, P.E., Rossetti, L., 2003. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest., 111(2):225-230.

[18] Reilly, M.P., Lehrke, M., Wolfe, M.L., Rohatgi, A., Lazar, M.A., Rader, D.J., 2005. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111(7):932-939.

[19] Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., Lazar, M.A., 2001a. The hormone resistin links obesity to diabetes. Nature, 409(6818):307-312.

[20] Steppan, C.M., Brown, E.J., Wright, C.M., Bhat, S., Banerjee, R.R., Dai, C.Y., Enders, G.H, Silberg, D.G., Wen, X., Wu, G.D., Lazar, M.A., 2001b. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA, 98(2):502-506.

[21] Steppan, C.M., Wang, J., Whiteman, E.L., Birnbaum, M.J., Lazar, M.A., 2005. Activation of SOCS-3 by resistin. Mol. Cell. Biol., 25(4):1569-1575.

[22] Verma, S., Anderson, T.J., 2002. Fundamentals of endothelial function for the clinical cardiologist. Circulation, 105(5):546-549.

[23] Verma, S., Li, S.H., Wang, C.H., Fedak, P.W., Li, R.K., Weisel, R.D., Mickle, D.A., 2003. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation, 108(6):736-740.

[24] Yang, R.Z., Huang, Q., Xu, A., McLenithan, J.C., Eisen, J.A., Shuldiner, A.R., Alkan, S., Gong, D.W., 2003. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem. Biophys. Res. Commun., 310(3):927-935.

[25] Zhou, L., Li, Y., Xia, T., Feng, S., Chen, X., Yang, Z., 2006. Resistin overexpression impaired glucose tolerance in hepatocytes. Eur. Cytokine. Netw., 17(3):189-195.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - Journal of Zhejiang University-SCIENCE